Desmopressin therapy in children and adults: pharmacological considerations and clinical implications.
Xinyi ChinShao Wei TeoSoo Ting LimYong Hong NgHow Chuan HanFabian Kok Peng YapPublished in: European journal of clinical pharmacology (2022)
The risk of hyponatremia, albeit small, can be reduced by adhering to the indication-specific doses and taking steps to govern the safe prescription of the drug. Further paediatric clinical trials are awaited to expand the evidence base of childhood desmopressin therapy.